What does non-eligibility for myoma surgery mean in the context of sequential prescription of ulipristal acetate?
Sign Up to like & getrecommendations! Published in 2020 at "Journal of gynecology obstetrics and human reproduction"
DOI: 10.1016/j.jogoh.2020.101688
Abstract: Ulipristal Acetate (UPA) is the only selective progesterone receptor modulator currently approved for medical management of myomas. Following several cases of liver toxicity during UPA treatment, new recommendations of PRAC (Pharmacovigilance Risk Assessment Committee) and… read more here.
Keywords: surgery; ulipristal acetate; non eligibility; eligibility myoma ... See more keywords